A small company in London, UK, says it can turn white blood cells into cells capable of regenerating damaged or diseased tissues. This could transform the treatment of everything from heart disease to Parkinson’s.

Its “miracle” hinges on an antibody that binds to a receptor on the cell surface and allegedly triggers “retrodifferentiation.”